322 related articles for article (PubMed ID: 3037889)
1. Clinical experience with converting-enzyme inhibitors in hypertension.
Weber MA
Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):45-51. PubMed ID: 3037889
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of captopril (Tensiomin) in patients with hypertension.
Török E; Bíró V; Wagner M; Kósa E; Podmaniczky M; Cseh K
Acta Physiol Hung; 1988; 72 Suppl():51-65. PubMed ID: 2908092
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibitors: are they all alike?
Case DB
J Clin Hypertens; 1987 Sep; 3(3):243-56. PubMed ID: 2822859
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibitors in hypertension: a review.
Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of enalapril in moderate to severe essential hypertension.
Walker JF; Kulaga SF; Kramsch DM
J Hypertens Suppl; 1984 Dec; 2(2):S107-11. PubMed ID: 6100871
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
7. Different effects of two angiotensin converting enzyme inhibitors in primary hypertension--a comparison of captopril and enalapril.
Karlberg BE; Sjöstrand A; Ohman KP
J Hypertens Suppl; 1986 Dec; 4(5):S432-4. PubMed ID: 3033182
[TBL] [Abstract][Full Text] [Related]
8. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
9. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
Vlasses PH; Larijani GE; Conner DP; Ferguson RK
Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
[TBL] [Abstract][Full Text] [Related]
10. [Effects of angiotensin-converting enzyme inhibitors in hypertension].
Rahn KH
Z Kardiol; 1988; 77 Suppl 3():69-71. PubMed ID: 2850690
[TBL] [Abstract][Full Text] [Related]
11. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
[TBL] [Abstract][Full Text] [Related]
12. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
Abrams WB; Davies RO; Ferguson RK
Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of captopril-enalapril replacement therapy in hypertensive patients under ambulatory blood pressure monitoring].
Ruszty L; Hidas I; Iványi J; Dudás M; Molnár S
Orv Hetil; 1996 Dec; 137(51):2851-4. PubMed ID: 9679620
[TBL] [Abstract][Full Text] [Related]
14. ACE inhibitors as initial therapy for hypertension.
Schoenberger JA
Am Fam Physician; 1988 Apr; 37(4):139-46. PubMed ID: 3282415
[TBL] [Abstract][Full Text] [Related]
15. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics.
Chan PS; Ronsberg MA; Cervoni P
Fed Proc; 1984 Apr; 43(5):1346-50. PubMed ID: 6200364
[TBL] [Abstract][Full Text] [Related]
16. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
Paran E; Anson O; Neumann L
Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892
[TBL] [Abstract][Full Text] [Related]
17. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B
Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
[TBL] [Abstract][Full Text] [Related]
18. Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
Cody RJ; Laragh JH; Atlas SA; Case DB
J Hypertens Suppl; 1983 Oct; 1(1):77-84. PubMed ID: 6085835
[TBL] [Abstract][Full Text] [Related]
19. Evolution of angiotensin-converting enzyme inhibitors.
Wyvratt MJ
Clin Physiol Biochem; 1988; 6(3-4):217-29. PubMed ID: 2849521
[TBL] [Abstract][Full Text] [Related]
20. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
